HDAC9 and diabetes mellitus: From both a mechanistic and a translational point of view, the pathway identified in the present study will provide a strong foundation on which HDAC inhibition may serve as the novel therapeutic target to prevent the progression of diabetes-induced cardiac dysfunction.